Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation

被引:73
作者
Pruitt, K
Pruitt, WM
Bilter, GK
Westwick, JK
Der, CJ
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] Celgene, Signal Res Div, San Diego, CA 92121 USA
关键词
D O I
10.1074/jbc.M203964200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activated Ras, but not Raf, causes transformation of RIE-1 epithelial cells, supporting the importance of Raf-independent pathways in mediating Ras transformation. The p38 and JNK mitogen-activated protein kinase cascades are activated by Ras via Raf-independent effector function. Therefore, we determined whether p38 and JNK activation are involved in Ras transformation of RIE-1 epithelial cells. Rather surprisingly, we found that pharmacologic inhibition of p38, together with Raf activation of ERK, was sufficient to mimic the morphologic and growth transformation caused by oncogenic Ras. p38 inhibition together with ERK activation also caused the same alterations in cyclin D1 and p21(CIP1) expression caused by Ras and induced an autocrine growth factor loop important for transformation. Finally, in contrast to p38, we found that JNK activation promoted Ras transformation, and that Ras deregulation of p38 and JNK was not mediated by activation of the Rac small GTPase. We conclude that a key action of Raf-independent effector pathways important for Ras transformation may involve inhibition of p38 and activation of JNK.
引用
收藏
页码:31808 / 31817
页数:10
相关论文
共 50 条
  • [1] TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS
    ALBANESE, C
    JOHNSON, J
    WATANABE, G
    EKLUND, N
    VU, D
    ARNOLD, A
    PESTELL, RG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23589 - 23597
  • [2] Ras and Rho GTPases: A family reunion
    Bar-Sagi, D
    Hall, A
    [J]. CELL, 2000, 103 (02) : 227 - 238
  • [3] BOS JL, 1989, CANCER RES, V49, P4682
  • [4] Increasing complexity of Ras signaling
    Campbell, SL
    Khosravi-Far, R
    Rossman, KL
    Clark, GJ
    Der, CJ
    [J]. ONCOGENE, 1998, 17 (11) : 1395 - 1413
  • [5] P21RAS IS MODIFIED BY A FARNESYL ISOPRENOID
    CASEY, PJ
    SOLSKI, PA
    DER, CJ
    BUSS, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) : 8323 - 8327
  • [6] The p38 pathway provides negative feedback for Ras proliferative signaling
    Chen, G
    Hitomi, M
    Han, JH
    Stacey, DW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) : 38973 - 38980
  • [7] Essential role for oncogenic Ras in tumour maintenance
    Chin, L
    Tam, A
    Pomerantz, J
    Wong, M
    Holash, J
    Bardeesy, N
    Shen, Q
    O'Hagan, R
    Pantginis, J
    Zhou, H
    Horner, JW
    Cordon-Cardo, C
    Yancopoulos, GD
    DePinho, RA
    [J]. NATURE, 1999, 400 (6743) : 468 - 472
  • [8] Clark G. J., 1993, GTPASES BIOL, DOI [10.1007/978-3-642-78267-1_18, DOI 10.1007/978-3-642-78267-1_18]
  • [9] p120 GAP modulates Ras activation of Jun kinases and transformation
    Clark, GJ
    Westwick, JK
    Der, CJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1677 - 1681
  • [10] SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1
    CUENDA, A
    ROUSE, J
    DOZA, YN
    MEIER, R
    COHEN, P
    GALLAGHER, TF
    YOUNG, PR
    LEE, JC
    [J]. FEBS LETTERS, 1995, 364 (02) : 229 - 233